BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21924256)

  • 1. Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo.
    Joeng KS; Schumacher CA; Zylstra-Diegel CR; Long F; Williams BO
    Dev Biol; 2011 Nov; 359(2):222-9. PubMed ID: 21924256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition.
    Riddle RC; Diegel CR; Leslie JM; Van Koevering KK; Faugere MC; Clemens TL; Williams BO
    PLoS One; 2013; 8(5):e63323. PubMed ID: 23675479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lrp5 and Lrp6 play compensatory roles in mouse intestinal development.
    Zhong Z; Baker JJ; Zylstra-Diegel CR; Williams BO
    J Cell Biochem; 2012 Jan; 113(1):31-8. PubMed ID: 21866564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall.
    Snowball J; Ambalavanan M; Cornett B; Lang R; Whitsett J; Sinner D
    Dev Biol; 2015 May; 401(2):264-75. PubMed ID: 25727890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2
    Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K
    Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.
    Ahn Y; Sims C; Logue JM; Weatherbee SD; Krumlauf R
    Development; 2013 Feb; 140(3):583-93. PubMed ID: 23293290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration.
    Lim KE; Bullock WA; Horan DJ; Williams BO; Warman ML; Robling AG
    Bone; 2021 Feb; 143():115708. PubMed ID: 33164872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.
    Goel S; Chin EN; Fakhraldeen SA; Berry SM; Beebe DJ; Alexander CM
    J Biol Chem; 2012 May; 287(20):16454-66. PubMed ID: 22433869
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Yadav PS; Feng S; Cong Q; Kim H; Liu Y; Yang Y
    Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34172578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity.
    Hsieh JC; Lee L; Zhang L; Wefer S; Brown K; DeRossi C; Wines ME; Rosenquist T; Holdener BC
    Cell; 2003 Feb; 112(3):355-67. PubMed ID: 12581525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts.
    Sebastian A; Hum NR; Murugesh DK; Hatsell S; Economides AN; Loots GG
    PLoS One; 2017; 12(11):e0188264. PubMed ID: 29176883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin.
    Sun T; Li CT; Xiong L; Ning Z; Leung F; Peng S; Lu WW
    PLoS One; 2017; 12(2):e0171281. PubMed ID: 28158288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast.
    Frey JL; Li Z; Ellis JM; Zhang Q; Farber CR; Aja S; Wolfgang MJ; Clemens TL; Riddle RC
    Mol Cell Biol; 2015 Jun; 35(11):1979-91. PubMed ID: 25802278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygosity for an inactivating mutation in low-density lipoprotein-related receptor 6 (Lrp6) increases osteoarthritis severity in mice after ligament and meniscus injury.
    Joiner DM; Less KD; Van Wieren EM; Hess D; Williams BO
    Osteoarthritis Cartilage; 2013 Oct; 21(10):1576-85. PubMed ID: 23756208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
    Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
    Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The canonical Wnt signaling activator, R-spondin2, regulates craniofacial patterning and morphogenesis within the branchial arch through ectodermal-mesenchymal interaction.
    Jin YR; Turcotte TJ; Crocker AL; Han XH; Yoon JK
    Dev Biol; 2011 Apr; 352(1):1-13. PubMed ID: 21237142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
    Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
    Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6.
    MacDonald BT; Semenov MV; Huang H; He X
    PLoS One; 2011; 6(8):e23537. PubMed ID: 21887268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.